ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 47 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,385 | -46.9% | 10,707 | -33.5% | 0.00% | – |
| Q2 2023 | $119,469 | +130.9% | 16,101 | +194.0% | 0.00% | – |
| Q1 2023 | $51,748 | -11.2% | 5,476 | +0.1% | 0.00% | – |
| Q4 2022 | $58,277 | +57.5% | 5,472 | +8.0% | 0.00% | – |
| Q3 2022 | $37,000 | +48.0% | 5,067 | +0.2% | 0.00% | – |
| Q2 2022 | $25,000 | -3.8% | 5,059 | +0.5% | 0.00% | – |
| Q1 2022 | $26,000 | -13.3% | 5,036 | +0.0% | 0.00% | – |
| Q4 2021 | $30,000 | -38.8% | 5,035 | -8.6% | 0.00% | – |
| Q3 2021 | $49,000 | +308.3% | 5,510 | +255.7% | 0.00% | – |
| Q2 2021 | $12,000 | +9.1% | 1,549 | +12.7% | 0.00% | – |
| Q1 2021 | $11,000 | -91.9% | 1,374 | -92.1% | 0.00% | – |
| Q4 2020 | $136,000 | +2166.7% | 17,380 | +2954.5% | 0.00% | – |
| Q3 2020 | $6,000 | – | 569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |